Friday, 27 May 2022
  
Login

Australia's most trusted
source of pharma news

Friday, 27 May 2022
News

Review caves in to pressure

Posted 24 January 2022 AM

In an abrupt about-face, the National Medicines Policy Review team has reversed a decision to keep the submissions it received under wraps - but the move has been branded too little, too late.

After a campaign spearheaded by consumer advocacy group Better Access Australia (BAA) calling for transparency, 120 of 156 submissions were published on the Department of Health website on Friday. Fourteen of the published group came from major pharmacos plus one from Medicines Australia.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (9)

Sales & Customer Relations (38)

Access & Reimbursement (4)

Clinical & Medical, R&D (12)

Regulatory, Pharmacovigilance & QA (5)

Devices (2)

Other (28)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.